Liver Immune-related Adverse Effects of Programmed Cell Death 1 (PD-1) and Programmed Cell Death Ligand 1 (PD-L1) Inhibitors: A Propensity Score Matched Study with Competing Risk Analyses

作者:Zhou, J.*; Chauy, Y. -L. A.; Yooy, J. W.; Lee, S.; Ng, K.; Dee, E. C.; Liu, T.; Wai, A. K. C.; Zhang, Q.; Tse, G.
来源:CLINICAL ONCOLOGY, 2022, 34(7): E316-E317.
DOI:10.1016/j.clon.2022.03.006